Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Sandler

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Urology|October 25, 2021
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate CancerTimothy J Daskivich, Michael Luu, Stephen J Freedland, et al.
Physics in Medicine and Biology|November 8, 2018
Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changesYi Lao, John David, Amin Mirhadi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2012
The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapyHanan Amro, Daniel A Hamstra, Daniel L Mcshan, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patientsYong Yue, Arsen Osipov, Benedick Fraass, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2006
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceMack Roach, Gerald Hanks, Howard Thames, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trialElizabeth Kent, Howard Sandler, James Montie, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 3, 2014
Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancerWensha Yang, Robert Reznik, Benedick A Fraass, et al.
Statistical Methods in Medical Research|September 3, 2016
A two-stage model in a Bayesian framework to estimate a survival endpoint in the presence of confounding by indicationCarine Bellera, Cécile Proust-Lima, Lawrence Joseph, et al.
Cancer|May 23, 2026
Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysisJohnathan Zeng, Ming-Hui Chen, Jing Wu, et al.
Radiation Oncology (London, England)|October 5, 2018
Novel 4D-MRI of tumor infiltrating vasculature: characterizing tumor and vessel volume motion for selective boost volume definition in pancreatic radiotherapyWensha Yang, Zhaoyang Fan, Zixin Deng, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Urology|October 25, 2021
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate CancerTimothy J Daskivich, Michael Luu, Stephen J Freedland, et al.
Physics in Medicine and Biology|November 8, 2018
Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changesYi Lao, John David, Amin Mirhadi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2012
The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapyHanan Amro, Daniel A Hamstra, Daniel L Mcshan, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patientsYong Yue, Arsen Osipov, Benedick Fraass, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2006
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceMack Roach, Gerald Hanks, Howard Thames, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trialElizabeth Kent, Howard Sandler, James Montie, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 3, 2014
Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancerWensha Yang, Robert Reznik, Benedick A Fraass, et al.
Statistical Methods in Medical Research|September 3, 2016
A two-stage model in a Bayesian framework to estimate a survival endpoint in the presence of confounding by indicationCarine Bellera, Cécile Proust-Lima, Lawrence Joseph, et al.
Cancer|May 23, 2026
Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysisJohnathan Zeng, Ming-Hui Chen, Jing Wu, et al.
Radiation Oncology (London, England)|October 5, 2018
Novel 4D-MRI of tumor infiltrating vasculature: characterizing tumor and vessel volume motion for selective boost volume definition in pancreatic radiotherapyWensha Yang, Zhaoyang Fan, Zixin Deng, et al.
Pageof 12